Century Therapeutics (IPSC) announced the appointments of Han Lee, Ph.D., M.B.A., and Martin Murphy, Ph.D., to its Board of Directors. As part of their appointments, Dr. Lee will serve as a member of the Audit and the Compensation Committees and Dr. Murphy will serve as a member of the Compensation and the Nominating and Corporate Governance Committees.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IPSC:
- Century Therapeutics downgraded to Market Perform from Outperform at Leerink
- Century Therapeutics Reports Positive Q3 2025 Earnings
- Century Therapeutics Launches Type 1 Diabetes Program
- Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
- Century Therapeutics announces new beta islet program for Type 1 diabetes